Stock Rich List
Nasdaq: TVTX

Travere Therapeutics insiders

The officers, directors and 10% owners of Travere Therapeutics, Inc. who hold the most stock, valued at the live TVTX price.

$48.30
TVTX today −$1.9M (−3.86%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
7
Their TVTX stock
$48.1M
Market value
$4.64B
Held by ranked insiders
1.04%

Insiders by value of TVTX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Eric M. DubeCHIEF EXECUTIVE OFFICER432,886$20.9M0.45%5011th
2Steve AselageDirector146,919$7.1M0.15%10719th
3Peter HeermaEVP, CHIEF COMMERCIAL OFFICER117,066$5.7M0.12%13290th
4Elizabeth E. ReedChief Legal Officer and GC105,389$5.1M0.11%14278th
5Jeffrey A. MecklerDirector91,500$4.4M<0.1%14186th
6Gary A. LyonsDirector61,500$3.0M<0.1%4752nd
7Roy D. BaynesDirector41,500$2.0M<0.1%10499th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Travere Therapeutics; see each profile for the filing.